NEW YORK, April 1, 2021 /PRNewswire/ -- The selective serotonin reuptake inhibitors (SSRIs) market is poised to grow by $ 809.73 mn during 2021-2025, progressing at a CAGR of about 4% during the forecast period. View Exclusive report talking about Market scenarios, Estimates, the impact...
from PR Newswire: https://ift.tt/2PrshTW
No comments:
Post a Comment